Consequence of collective cell invasion in glioblastoma
Consequence of collective cell invasion in glioblastoma
批准号:
8957737
负责人:
Justin D. Lathia
金额:
$17.24万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-01 至 2017-06-30
关键词:
AdhesionsAttenuatedAutomobile DrivingBehaviorBiological ModelsBlood VesselsBrainCandidate Disease GeneCaringCell AdhesionCell PolarityCell modelCellsCharacteristicsClinicalCommunicationCytoskeletonDataDevelopmentDistantDrosophila genusExcisionGenesGenetic ScreeningGlioblastomaGliomaGoalsGrowthHeterogeneityHistocompatibility TestingHomeostasisHumanIndividualInfiltrationIntercellular JunctionsInvadedLeadLinkMalignant NeoplasmsMalignant neoplasm of brainMediatingMesenchymalModelingMolecularOrganOutcomeOvarianPathway interactionsPatientsPatternPopulationPrimary NeoplasmProcessProteinsRNA InterferenceRadiationRadiosurgeryRecurrenceReportingResearchResistanceRoleSignal TransductionStagingSurfaceTestingTherapeuticTissuesTranslatingTumor Cell InvasionXenograft procedureadvanced diseaseaggressive therapybasecancer stem cellcancer therapycancer typecell motilitychemotherapydesigngene functioninsightmigrationneoplastic cellnovelorgan growthoutcome forecastpublic health relevancerho GTP-Binding Proteinsscreeningself renewing cellself-renewaltherapeutic targettherapy resistanttumortumor growthtumorigenicwhite matter
中文摘要
描述(申请人提供):肿瘤细胞侵袭,肿瘤细胞脱离原发肿瘤并扩散到远处器官的过程,标志着向更晚期疾病的过渡,并在很大程度上导致了许多癌症类型的致命性。单个肿瘤细胞的迁移已经被很好地描述,但越来越多的证据表明,肿瘤细胞也作为一个集体或一组通过细胞连接保持黏附和通讯的细胞迁移。据报道,作为集体迁移的细胞会更深入地侵入器官,并分散到多种组织类型中。胶质母细胞瘤(GBM)是最常见的脑部恶性肿瘤,其特征之一是肿瘤细胞侵入脑实质,这一特征极大地导致了治疗后肿瘤的高复发率。我们无法成功地治疗GBM也是由于存在一种称为癌症干细胞(CSCs)的自我更新细胞群,这种细胞群具有治疗抗性。与非干细胞肿瘤细胞相比,CSCs具有更强的迁移能力,尽管CSCs侵袭的机制和这种侵袭的后果尚未确定。这个项目的翻译目标是对CSCs的集体细胞迁移进行机制研究,并确定这种入侵对GBM进展的影响。根据我们的初步数据显示CSCs的集体细胞迁移,我们假设集体细胞入侵对GBM的生长是必不可少的,并且可以通过损害控制集体细胞入侵的分子过程来破坏。为了深入了解这些分子过程,我们对果蝇进行了筛查,并确定了负责集体入侵的新基因。利用从果蝇发育到人类CSC模型的综合方法,我们将通过以下目的来验证这一假说:1)集体入侵需要动态的细胞-细胞连接和黏附;2)破坏集体细胞入侵会减少GBM的生长并增加标准护理治疗的疗效。该项目的长期目标是将获得的关于GBM CSCs集体细胞迁移和侵袭的信息转化为有用的临床治疗的抑制策略。
英文摘要
DESCRIPTION (provided by applicant): Tumor cell invasion, the process by which tumor cells break away from the primary tumor and spread to distant organs, signals a transition to more advanced disease and greatly contributes to the lethality of many cancer types. The migration of single tumor cells has been well described, but mounting evidence suggests that tumor cells also migrate as a collective, or a group of cells that maintain adhesion and communication through cellular junctions. Cells migrating as a collective have been reported to invade more deeply into organs and to disperse into multiple tissue types. One hallmark of the most common malignant brain tumor, glioblastoma (GBM), is the invasion of tumor cells into the brain parenchyma, a characteristic that greatly contributes to the high rate of tumor recurrence after therapy. Our inability to successfully treat GBM is also driven by the presence of a therapeutically resistant population of self-renewing cells termed cancer stem cells (CSCs). CSCs have been shown to have an enhanced ability to migrate compared with non-stem tumor cells (non-CSCs), although the mechanisms by which CSCs invade and the consequences of this invasion have yet to be determined. The translational goal of this project is to conduct mechanistic studies into collective cell migration by CSCs and to determine the impact of this invasion on GBM progression. Based on our preliminary data showing collective cell migration of CSCs, we hypothesize that collective cell invasion is essential for GBM growth and can be disrupted by compromising the molecular processes governing collective cell invasion. To gain insight into these molecular processes, we performed a screen in Drosophila and identified novel genes responsible for collective invasion. Using an integrative approach spanning Drosophila development to human CSC models, we will interrogate this hypothesis by investigating the following aims: 1) that collective invasion requires dynamic cell-cell junctions and adhesion and 2) that disrupting collective cell invasion decreases GBM growth and increases the efficacy of standard-of-care therapy. The long-term goal of this project is to translate the information gained about collective cell migration and invasion of GBM CSCs to inhibition strategies useful as clinical therapies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma
-
批准号:10615850
-
项目类别:
-
资助金额:$65.47万
-
财政年份:2022
-
负责人:Justin D. Lathia
-
依托单位:
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma
-
批准号:10444016
-
项目类别:
-
资助金额:$45.43万
-
财政年份:2022
-
负责人:Justin D. Lathia
-
依托单位:
Sex-based Differences in Glioma
-
批准号:10653075
-
项目类别:
-
资助金额:$201.73万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
-
批准号:10653091
-
项目类别:
-
资助金额:$36.17万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
-
批准号:10023716
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Core A: Administrative Core
-
批准号:10023717
-
项目类别:
-
资助金额:$13.36万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Core A: Administrative Core
-
批准号:10463732
-
项目类别:
-
资助金额:$12.92万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Core A: Administrative Core
-
批准号:10653098
-
项目类别:
-
资助金额:$13.1万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Core A: Administrative Core
-
批准号:10263184
-
项目类别:
-
资助金额:$6.0万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
-
批准号:10463731
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Sex-based Differences in Glioma
-
批准号:10463728
-
项目类别:
-
资助金额:$201.97万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Project 3: Sex-specific differences in the tumor microenvironment alter glioblastoma growth
-
批准号:10263183
-
项目类别:
-
资助金额:$16.85万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Sex-based Differences in Glioma
-
批准号:10263180
-
项目类别:
-
资助金额:$92.68万
-
财政年份:2020
-
负责人:Justin D. Lathia
-
依托单位:
Deciphering MDSC function for GBM targeting
-
批准号:9762334
-
项目类别:
-
资助金额:$41.68万
-
财政年份:2019
-
负责人:Justin D. Lathia
-
依托单位:
Deciphering MDSC function for GBM targeting
-
批准号:10457875
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2019
-
负责人:Justin D. Lathia
-
依托单位:
Deciphering MDSC function for GBM targeting
-
批准号:10223446
-
项目类别:
-
资助金额:$43.49万
-
财政年份:2019
-
负责人:Justin D. Lathia
-
依托单位:
Deciphering MDSC function for GBM targeting
-
批准号:9900079
-
项目类别:
-
资助金额:$40.35万
-
财政年份:2019
-
负责人:Justin D. Lathia
-
依托单位:
Connexins and glioblastoma progression
-
批准号:9552265
-
项目类别:
-
资助金额:$34.68万
-
财政年份:2015
-
负责人:Justin D. Lathia
-
依托单位:
Consequence of collective cell invasion in glioblastoma
-
批准号:9097665
-
项目类别:
-
资助金额:$20.68万
-
财政年份:2015
-
负责人:Justin D. Lathia
-
依托单位:
Connexins and glioblastoma progression
-
批准号:9146415
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2015
-
负责人:Justin D. Lathia
-
依托单位:
海外基金